• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Medical press releases may exaggerate results

Article

Hanover, N.H. - Some medical press releases use formats that exaggeratethe perceived importance of findings and do not routinely highlight studylimitations, according to a study published in a recent issue Journal ofthe American Medical Assn.

Recent Videos
Related Content
Derm In The News: September 1-7

Derm In The News: September 1-7

Article
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Podcast
Exploring the Perception of Digital Health Tools in Dermatology

Exploring the Perception of Digital Health Tools in Dermatology

Article
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Podcast
Approximately 65% of Dermatologists in Japan Report Dissatisfaction With Treatment Options for Severe Prurigo Nodularis

Approximately 65% of Dermatologists in Japan Report Dissatisfaction With Treatment Options for Severe Prurigo Nodularis

Article
Exploring Afamelanotide for Vitiligo: Insights into the CUV 105 Phase 3 Clinical Trial

Exploring Afamelanotide for Vitiligo: Insights into the CUV 105 Phase 3 Clinical Trial

Article
© 2024 MJH Life Sciences

All rights reserved.